metricas
covid
Buscar en
Acta Otorrinolaringológica Española
Toda la web
Inicio Acta Otorrinolaringológica Española Maxillary Sinus Cancer Review in 23 Patients Treated With Postoperative Radiothe...
Journal Information
Vol. 59. Issue 1.
Pages 6-10 (January 2008)
Share
Share
Download PDF
More article options
Vol. 59. Issue 1.
Pages 6-10 (January 2008)
Maxillary Sinus Cancer Review in 23 Patients Treated With Postoperative Radiotherapy
Revisión del cáncer del seno maxilar en 23 pacientes tratados con radioterapia posoperatoria
Visits
1067
Rubén D. Manriquea,
Corresponding author
rben03811@hotmail.com

Correspondence: Puerto Rico, 14, 3.o C. 36204 Vigo. Pontevedra. España.
, Leopoldo G. Deivea, Michel A. Ueharab, Roslyn K. Manriquec, José L. Rodrígueza, Carmelo Santidriana
a Departamento de Otorrinolaringología, Hospital do Meixoeiro, Vigo, Pontevedra, Spain
b Departamento de Otorrinolaringología, Hospital La Fe, Valencia, Spain
c Departamento de Oftalmología, Hospital Universitario La Paz, Madrid, Spain
This item has received
Article information
Abstract
Objective

To describe the survival and outcome of maxillary sinus cancer in patients managed with surgery and postoperative radiotherapy during the last 10 years in our hospital.

Patients and method

Descriptive, retrospective, nonrandomized study of 23 patients with cancer of the maxillary sinus managed at the Vigo University Hospital Complex, Spain, with radical surgery and post-operative radiotherapy, between 1995 and 2004.

Results

The 3-year actuarial survival was 47.8% and the adjusted actuarial survival was 60.8%. Permanent local tumour control was achieved in 60.8% of cases (14/23). Local tumour recurrence was the main cause of treatment failure (33.3%; 4/12). The most significant prognostic factors affecting local tumour control and survival were: clinical stage (P<.031), suprastructural location of the tumour (P<.001), and presence of positive resection margins (P<.001).

Conclusions

Local recurrence was found to be very high and generally the main cause of death. New treatment protocols should be assessed.

Key words:
Maxillary sinus cancer
Post-operative radiotherapy
Actuarial survival
Resumen
Objetivo

Describir el comportamiento del cáncer del seno maxilar y la experiencia acumulada durante 10 años en el manejo de este tipo de neoplasia en nuestro hospital mediante el tratamiento con cirugía y radioterapia postoperatoria.

Pacientes y método

El presente es un estudio descriptivo, retrospectivo y no aleatorizado, que se llevó a cabo en el Complejo Hospitalario Universitario de Vigo, con 23 pacientes con cáncer de seno maxilar que recibieron tratamiento con fines curativos entre los años 1995 y 2004. Todos fueron sometidos a cirugía radical y radioterapia postoperatoria.

Resultados

La supervivencia actuarial a 3 años fue del 47,8% y la corregida, del 60,8%. El control local permanente se consiguió en 14/23 (60,8%) pacientes. La causa principal de fracaso del tratamiento fue la recurrencia local 4/12 (33,3%). Los factores pronósticos más significativos que afectaron al control local y la supervivencia fueron: el estadio clínico (p<0,031), la localización del tumor en la supraestructura (p<0,001) y los márgenes de sección quirúrgicos positivos (p<0,001).

Conclusiones

La recurrencia local es muy alta y generalmente la principal causa de muerte. Hay que explorar nuevos protocolos de tratamiento.

Palabras clave:
Cáncer de seno maxilar
Radioterapia postoperatoria
Supervivencia actuarial

Article

These are the options to access the full texts of the publication Acta Otorrinolaringológica Española
Subscriber
Subscriber

If you already have your login data, please click here .

If you have forgotten your password you can you can recover it by clicking here and selecting the option “I have forgotten my password”
Subscribe
Subscribe to

Acta Otorrinolaringológica Española

Purchase
Purchase article

Purchasing article the PDF version will be downloaded

Price 19.34 €

Purchase now
Contact
Phone for subscriptions and reporting of errors
From Monday to Friday from 9 a.m. to 6 p.m. (GMT + 1) except for the months of July and August which will be from 9 a.m. to 3 p.m.
Calls from Spain
932 415 960
Calls from outside Spain
+34 932 415 960
E-mail
Article options
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos